Efficacy and Safety Phase III Clinical Study of VC005 Tablets in Subjects With Active Ankylosing Spondylitis.
Recruiting
Phase 3
Interventional Study
Active Ankylosing Spondylitis
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 – 70
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 420 (estimated)
- Sponsor
- Jiangsu vcare pharmaceutical technology co., LTD · Industry
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This clinical trial is a multicenter, randomized, double-blind, controlled phase III clinical study.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* The subject understands and voluntarily signs the informed consent form (ICF) and is willing and able to comply with the study protocol;
* The subject is between 18 and 70 years of age (including borderline values) at the time of signing the ICF, regardless of gender;
* The su…
Contacts